Supporting this notion, previous research had shown that Enalapril, an angiotensin-converting enzyme inhibitor with the ability to reduce insulin resistance [44,45], can also decrease the proliferation and production of hyaluronic acid in orbital fibroblasts from patients with GO [46]. The gene discussed is ACE; the disease is Insulin resistance.